United Therapeutics Corporation

UTHRNASDAQHealthcare● Active

$546.29

$-3.58(-0.65%)

Market Cap$23.2B

P/E Ratio—

52W High$609.35

52W Low$272.12

Avg Volume546K

Open$545.50

Beta0.57

Insider Trades Ownership Employees

United Therapeutics Corporation (UTHR) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · UTHR · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

1735

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

United Therapeutics Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

UTHR insider buying and selling by quarter

UTHR insider selling · UTHR insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

2.2M1.1M0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · UTHR ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

UTHR executive sell shares · UTHR board member insider trading · UTHR insider trading SEC filing

Showing 90 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Option	10,000	$117.76	$1.18M⚡	28,876	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	120	$539.64	$65K	28,756	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	480	$541.14	$260K	28,276	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	440	$542.78	$239K	27,836	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	1,086	$544.11	$591K	26,750	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	1,545	$544.94	$842K	25,205	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	1,129	$545.89	$616K	24,076	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	1,033	$547.00	$565K	23,043	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	2,749	$548.04	$1.51M⚡	20,294	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	1,298	$549.06	$713K	18,996	Form 4
Jun 4, 2026	EDGEMOND JAMES CFO AND TREASURER	Sale	120	$550.48	$66K	18,876	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Option	9,500	$146.03	$1.39M⚡	50,013	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	120	$539.51	$65K	49,893	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	473	$541.08	$256K	49,420	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	112	$542.50	$61K	49,308	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	396	$543.11	$215K	48,912	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	1,470	$544.24	$800K	47,442	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	1,186	$545.18	$647K	46,256	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	1,202	$546.14	$656K	45,054	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	1,525	$547.53	$835K	43,529	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	1,676	$548.26	$919K	41,853	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	780	$549.24	$428K	41,073	Form 4
Jun 4, 2026	ROTHBLATT MARTINE A Chairperson & CEO · Director	Sale	560	$550.46	$308K	40,513	Form 4
Jun 4, 2026	MAHON PAUL A EVP & GENERAL COUNSEL	Option	8,300	$146.03	$1.21M⚡	53,472	Form 4
Jun 4, 2026	MAHON PAUL A EVP & GENERAL COUNSEL	Sale	200	$539.76	$108K	53,272	Form 4

EDGEMOND JAMES

CFO AND TREASURER

Option

Date

Jun 4

10,000

Price

$117.76

Value

$1.18M ⚡

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

120

Price

$539.64

Value

$65K

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

480

Price

$541.14

Value

$260K

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

440

Price

$542.78

Value

$239K

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

1,086

Price

$544.11

Value

$591K

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

1,545

Price

$544.94

Value

$842K

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

1,129

Price

$545.89

Value

$616K

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

1,033

Price

$547.00

Value

$565K

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

2,749

Price

$548.04

Value

$1.51M ⚡

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

1,298

Price

$549.06

Value

$713K

View Form 4 on SEC.gov

EDGEMOND JAMES

CFO AND TREASURER

Sale

Date

Jun 4

120

Price

$550.48

Value

$66K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Option

Date

Jun 4

9,500

Price

$146.03

Value

$1.39M ⚡

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

120

Price

$539.51

Value

$65K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

473

Price

$541.08

Value

$256K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

112

Price

$542.50

Value

$61K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

396

Price

$543.11

Value

$215K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

1,470

Price

$544.24

Value

$800K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

1,186

Price

$545.18

Value

$647K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

1,202

Price

$546.14

Value

$656K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

1,525

Price

$547.53

Value

$835K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

1,676

Price

$548.26

Value

$919K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

780

Price

$549.24

Value

$428K

View Form 4 on SEC.gov

ROTHBLATT MARTINE A

Chairperson & CEO · Director

Sale

Date

Jun 4

560

Price

$550.46

Value

$308K

View Form 4 on SEC.gov

MAHON PAUL A

EVP & GENERAL COUNSEL

Option

Date

Jun 4

8,300

Price

$146.03

Value

$1.21M ⚡

View Form 4 on SEC.gov

MAHON PAUL A

EVP & GENERAL COUNSEL

Sale

Date

Jun 4

200

Price

$539.76

Value

$108K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About UTHR insider trading

UTHR insider trades

United Therapeutics Corporation (UTHR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ROTHBLATT MARTINE A (Chairperson & CEO · Director), EDGEMOND JAMES (CFO AND TREASURER), MAHON PAUL A (EVP & GENERAL COUNSEL). Over the past 12 months, 3 insiders have filed transactions with the SEC. UTHR insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For United Therapeutics Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

UTHR insider trading · 5 questions

The insiders of United Therapeutics Corporation (UTHR) include executives and directors such as ROTHBLATT MARTINE A (Chairperson & CEO · Director), EDGEMOND JAMES (CFO AND TREASURER), MAHON PAUL A (EVP & GENERAL COUNSEL), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

UTHR board member insider tradingwho are UTHR insidersUTHR insider rosterUnited Therapeutics Corporation executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026